The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.
Psychological well‐being in patients on ‘adequate’ doses of l‐thyroxine: results of a large, controlled community‐based questionnaire study
Abstract
Summary: objective Over 1% of the UK population is receiving thyroid hormone replacement with l‐thyroxine (T4). However, many patients complain of persistent lethargy and related symptoms on T4 even with normal TSH levels. To date there has been no large study to determine whether this is related to thyroxine replacement or coincidental psychological morbidity. We have therefore attempted to address this issue using a large, community‐based study. design and patients Computerized prescribing records of five general practices were used to identify 961 patients who had been on thyroxine for a minimum of 4 months from a population of 63 000 (1·5%), along with age‐ and sex‐matched controls. All 1922 individuals were sent a two‐page questionnaire, made up of the short form of the General Health Questionnaire (GHQ‐12), designed to detect minor psychiatric disorders in the community, and a 12‐question ‘thyroid symptom questionnaire’ (TSQ) in the same format. A covering letter explained that we were interested in ‘how patients felt on medication’ and made no direct reference to thyroxine. measurements Scores from the GHQ and TSQ were marked for each individual using the GHQ and Likert scoring methods. Patients’ latest TSH measurements were obtained from laboratory records. Comparisons were then made on scores for the total GHQ‐12, TSQ and individual questions between patients (P) and control (C) groups. Separate analyses were made comparing the patients with a normal TSH (nP) and the control group. results Five hundred and ninety‐seven (62%) of the patients (P) and 551 (57%) of the controls (C) responded and fully completed at least one of the two questionnaire. Three hundred and ninety‐seven responding patients (nP) had a TSH estimation performed in the previous 12 months with the last result being in the local laboratory normal range for TSH (0·1–5·5 or 0·2–6·0 mU/l, according to the assay method used). The responding P, nP and C populations were well matched for age (59·96, 59·73, 59·35 years) and sex (85%, 83%, 87% female). The number of individuals scoring 3 or more on the GHQ‐12 (indicating ‘caseness’) was 21% higher in P than C [185/572 (32·3%) vs. 137/535 (25·6%), P = 0·014] and 26% higher in nP than C [131/381 (34·4%) vs. 137/535 (25·6%), P < 0·005]. Stronger differences were seen with the TSQ scores [C = 187/535 (35·0%), P = 273/583 (46·8%), P < 0·001, P vs. C; and nP = 189/381 (48·6%), P < 0·001, nP vs. C]. Differences existed in chronic drug use and chronic disease prevalence between the control and patient groups, but the differences in GHQ and TSQ scores between the groups remained significant even after correction for these factors as well as age and sex in multiple regression analysis. conclusions This community‐based study is the first evidence to indicate that patients on thyroxine replacement even with a normal TSH display significant impairment in psychological well‐being compared to controls of similar age and sex. In view of the large numbers of people on thyroxine replacement, we believe that these differences, although not large, could contribute to significant psychological morbidity in a substantial number of individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients on levothyroxine display ongoing substantial impairment of psychological wellbeing compared with controls of similar age and sex.165”
From Hypothyroidism (2024) · cites this paper as [165]
In the citing paper
“Persistent symptoms in patients treated for hypothyroidism are common.”
From Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement (2023) · cites this paper as [4]
In the citing paper
“a proportion of individuals have significant dissatisfaction with it, including ongoing significant impairment in psychological well -being compared to controls of similar age and sex. 4 -8”
From Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement (2023) · cites this paper as [4]
In the citing paper
“There is now a consensus that a fraction of the LT4-treated hypothyroid patients with normal serum TSH levels remains symptomatic ( 6 , 7 , 23 , 24 ).”
From Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine+Liothyronine in Hypothyroidism (2021) · cites this paper as [6]
In the citing paper
“For some patients, however, the success story was limited by the persistence of residual cognitive symptoms and decrements in the quality of life (5–7).”
From Emerging Therapies in Hypothyroidism (2024) · cites this paper as [5]
In the citing paper
“However, a minority of the patients remain symptomatic despite the normalization of serum thyrotropin levels.”
From Emerging Therapies in Hypothyroidism (2024) · cites this paper as [5]
In the citing paper
“Limiting the analysis to patients with serum TSH in a narrow normal range (0.4-4.0 mU/l) gave similar outcomes: caseness was 35.1% in GHQ-12 and 48.5% in TSQ.”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [11]
In the citing paper
“After correction for age, sex, chronic diseases and chronic medication, the proportion of caseness was higher in patients than in controls, both in the GHQ-12 (34.4 vs. 25.6%,p = 0.012, odds ratio (OR) 1.48 [1.09-2.00])and in the TSQ (48.6 vs. 35.0%,p ! 0.001, OR 1.71 [1.29-2.25]).”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [11]
In the citing paper
“After correction for age, sex, chronic diseases and chronic medication, the proportion of caseness was higher in patients than in controls, both in the GHQ-12 (34.4 vs. 25.6%,p = 0.012, odds ratio (OR) 1.48 [1.09-2.00])and in the TSQ (48.6 vs. 35.0%,p ! 0.001, OR 1.71 [1.29-2.25]).”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [11]
In the citing paper
“The study provided evidence that patients on L-T4 replacement even with a normal serum TSH display significant impairment of psychological well-being compared to controls of similar age and sex.”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [11]
In the citing paper
“However, a proportion of individuals continue to suffer with symptoms despite achieving adequate biochemical correction.”
From Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee (2016) · cites this paper as [22]
In the citing paper
“Approximately 10%–15% of subjects with hypothyroidism on L-thyroxine (LT4) alone have persistent symptoms affecting their quality of life (QoL).”
In the citing paper
“Hypothyroid subjects on long-term LT4 alone have (a) a 15% excess of psychological caseness (5)”
In the citing paper
“We observed that in individuals on LT4 alone (n = 573), homozygosity for the Thr92Ala polymorphism was associated with reduced QoL (5).”
Citations
Cites
The Validity of Two Versions of the GHQ in the WHO Study of Mental Illness in General Health Care
GOLDBERG, D. P., GATER, R., SARTORIUS, N., USTUN, T. B., PICCINELLI, M., GUREJE, O., & RUTTER, C. (1997) · Psychological Medicine · doi:10.1017/s0033291796004242 · Cited by 3,657
The detection of psychiatric illness by questionnaire
Levy, R. (1973) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(73)90039-1 · Cited by 2,707
THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY
Tunbridge, W. M. G., Evered, D. C., Hall, R., Appleton, D. R., BREWIS, M., CLARK, F., Evans, J. G., Young, E. T., Bird, T., & Smith, P. (1977) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1977.tb01340.x · Cited by 2,665
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.7.979 · Cited by 1,485
The use of the General Health Questionnaire as an indicator of mental health in occupational studies
Banks, M. H., Clegg, C., Jackson, P. R., Kemp, N. J., Stafford, E. M., & Wall, T. D. (1980) · Journal of Occupational Psychology · doi:10.1111/j.2044-8325.1980.tb00024.x · Cited by 690
Andersen, S., Pedersen, K. M., Bruun, N. H., & Laurberg, P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8165 · Cited by 686
Larsen, P. R., Silva, J. E., & Kaplan, M. M. (1981) · Endocrine Reviews · doi:10.1210/edrv-2-1-87 · Cited by 546
Identification of a tHyroid Hormone Receptor That Is Pituitary-Specific
Hodin, R. A., Lazar, M. A., Wintman, B. I., Darling, D. S., Koenig, R. J., Larsen, P. R., Moore, D. D., & Chin, W. W. (1989) · Science · doi:10.1126/science.2539642 · Cited by 486
Bunevičius, R., Kažanavičius, G., Žalinkevičius, R., & Prange, A. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400603 · Cited by 482 · cited 3×
“Relative hypothyroidism on T4 therapy titrated to a normal TSH would also be consistent with the observation that additional T4 (Carr et al., 1988) or partial T3 supplementation (Bunevicius et al., 1999) results in increases in well-being.”
BackgroundMari, J. D. J., & Williams, P. R. (1985) · Psychological Medicine · doi:10.1017/s0033291700031500 · Cited by 469
Research works printed but not linked: 2
- Roberts N.D., 1996, Psychological problems in thyroid disease, British Thyroid Foundation Newsletter, 18, 3
- 10.1210/jc.82.3.771 · DOI
Cited by
Sorted by citations
Items 401–500 of 513
A combination of T3and T4for hypothyroidism?
Mishriki, Y. Y. (2004) · Postgraduate Medicine · doi:10.3810/pgm.2004.04.1491 · Cited by 2
Effect of Exogenous Thyroid Hormone Intake on the Interpretation of Serum TSH Test Results
Warmingham, P. (2010) · Cited by 2
McDermott, M., & Ridgway, E. C. (2009) · CRC Press eBooks · doi:10.3109/9781420070651-5 · Cited by 2
The choice of surgery in patients with diffuse toxic goiter
Vachev, A. N., Фролова, Е. В., Сахипов, Д. Р., & Морковских, Н. В. (2016) · Pirogov Russian Journal of Surgery · doi:10.17116/hirurgia2016813-17 · Cited by 2
Marcadores de función tiroidea (I). Evaluación de la actividad glandular
Galofré, J. C., Santos, S., & Salvador, J. (2016) · Revista de medicina de la Universidad de Navarra · doi:10.15581/021.50.7604 · Cited by 2
Weiss, R. E., & Refetoff, S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00077-0 · Cited by 2
Pathophysiology and Management Possibilities of Thyroid-Associated Depression
Ivanov, S. L., Bakalov, D. V., & Bocheva, G. (2022) · Acta Medica Bulgarica · doi:10.2478/amb-2022-0033 · Cited by 3
T3 and T4: Are we missing half the picture?
Klein, I. L. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80051-1 · Cited by 2
Measuring Impact of Benign Thyroid Diseases on Quality of Life
Watt, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64960-7 · Cited by 2
Thyroid-Specific Patient-Reported Outcome Measure (ThyPRO)
Watt, T. (2014) · Springer eBooks · doi:10.1007/978-94-007-0753-5_3857 · Cited by 2
Fattori, A., Neri, L., & Lania, A. G. (2019) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02736-0 · Cited by 1
Oh, J. W., Lee, S.-J., Kim, B., Lee, C.-S., Cha, B., Lee, D., Seo, J.-Y., Lee, Y.-J., Lee, J.-H., Lee, Y. J., et al. (2020) · Chronobiology in Medicine · doi:10.33069/cim.2020.0015 · Cited by 1
Tsanava, I. A., Bulgakova, S. V., & Melikova, A. V. (2021) · Russian Clinical Laboratory Diagnostics · doi:10.51620/0869-2084-2021-66-5-261-265 · Cited by 1
Is euthyroidism within reach for all?
Jonklaas, J. (2023) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2023.2267120 · Cited by 1
“Unfortunately, clinical euthyroidism, based on patient-reported symptoms or patient satisfaction, is not guaranteed even if the TSH is normal [19,20].”
BackgroundHarsini, A. R., Mohajeri‐Tehrani, M. R., Sajjadi‐Jazi, S. M., Naeini, F., Valisoltani, N., Sadeghi, E., Mohammadi, H., & Hosseini, S. (2024) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2024.02.030 · Cited by 1
Prevalence and risk factors of musculoskeletal symptoms among treated coeliac disease patients
Tillqvist, S., Paavola, S., Pasternack, C., Huhtala, H. S. A., Salmi, T. T., Kurppa, K., Kaukinen, K., & Laurikka, P. (2025) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2025.2560000 · Cited by 1
“The reasons for this remain uncertain, but it seems that some patients with thyroid disease continue to have complaints despite being euthyroid [35,36].”
Jaglan, G., Balkrishna, A., & Varshney, A. (2026) · Annals of Neurosciences · doi:10.1177/09727531261440119 · Cited by 1
Options of Replacement Therapy in Hypothyroidism
Valentine, V., Galina, A., & Morgunov, T. (2012) · InTech eBooks · doi:10.5772/31226 · Cited by 1
The role of long term use of antithyroid drugs in Graves’ disease
Abhayaratna, S., & Somasundaram, N. (2013) · Sri Lanka Journal of Diabetes Endocrinology and Metabolism · doi:10.4038/sjdem.v3i1.5503 · Cited by 1
“However, one study has shown that patients on thyroxine replacement, even with normal TSH levels, demonstrate significant impairment in psychological well-being compared to control individuals (6).”
BackgroundTerapia sostitutiva combinata con L-T4 e L-T3 nell’ipotiroidismo
Biondi, B., Celi, F. S., Duntas, L. H., Isidori, A. M., Pontecorvi, A., Salvatore, D., Vitti, P., & Trimarchi, F. (2015) · L Endocrinologo · doi:10.1007/s40619-015-0158-6 · Cited by 1
Hypothyroidism: To Screen or not to Screen, that is the Question?
Bhargava, A. (2015) · Journal of Thyroid Disorders & Therapy · doi:10.4172/2167-7948.1000e124 · Cited by 1
Refinement and Further Application of the Qualities of Sore Throat Index (QUASTI)
Schachtel, B. P., Smith, A. B., & Shephard, A. (2020) · Pain Management · doi:10.2217/pmt-2020-0002 · Cited by 1
Nygaard, B. (2022) · doi:10.1093/med/9780198870197.003.0072 · Cited by 1
Diagnosis and Treatment of Hypothyroidism
Ashraff, S., & Razvi, S. (2017) · Endocrinology · doi:10.1007/978-3-319-29195-6_14-1 · Cited by 1
Diab, N., Desale, S., Danielsen, M., Köhrle, J., Shara, N., & Jonklaas, J. (2022) · Metabolites · doi:10.3390/metabo12060476 · Cited by 1
“There is a rich literature describing patient dissatisfaction with LT4 therapy [17,18] and patient preferences for synthetic combination therapy and desiccated thyroid extract [1,19,20].”
BackgroundThe effects of calcitonin on quality of life in hypothyroid patients – A pilot study
Rahman, W., Ștefan, S., Ahmed, A. A., Siddiqi, M., Malek, R., Lamos, E. M., & Munir, K. M. (2023) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2023.100125 · Cited by 1
SLOCUM, K., & BİLİCAN, I. (2023) · Turkiye Klinikleri Journal of Health Sciences · doi:10.5336/healthsci.2023-97638 · Cited by 1
“22 Recent studies demonstrate that many continue to have lower QOL in spite of being in the euthyroid state.”
BackgroundJeong, J.-H., & Hwang, J. H. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14040331 · Cited by 1
“Small groups of people on LT4 monotherapy have reported not feeling as if they had achieved their premorbid well-being [23].”
BackgroundApproach to the Patient: Challenging Cases of Pediatric Thyrotoxicosis
Mooij, C. F., Zwaveling‐Soonawala, N., Hillebrand, J. J., & van Trotsenburg, A. S. P. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae592 · Cited by 1
Azizi, F., Moeini, A. S. H., Mehran, L., Masoumi, S., Abdi, H., Foroutan, S. M., Saghafinia, A. E., & Amouzegar, A. (2025) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2025.100395 · Cited by 3
“However, many hypothyroid patients complain of hypothyroid-like symptoms despite normal concentrations of serum thyroid hormones and thyrotropin (TSH) [4 – 9].”
Clinical thyroidology: beyond the 1970s’ TSH-T4 Paradigm
Lindner, H. H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1529791 · Cited by 2
Importance of Thyroid Hormone Replacement Therapy in Patients with Medullary Thyroid Cancer
Jonklaas, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-39412-1_13 · Cited by 1
Psychiatric disorders and thyroid disease
Migdal, A. L., & Hennessey, J. V. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-4975-1.00050-4 · Cited by 1
Leung, A. M. (2016) · Clinical Thyroidology · doi:10.1089/ct.2016;28.229-231 · Cited by 1
Does Normal TSH Mean Euthyroidism in L-T 4 Treatment?
Orgiazzi, J. (2016) · Clinical Thyroidology · doi:10.1089/ct.2016;28.325-328 · Cited by 1
Work Disability among People with Benign Thyroid Diseases in Denmark
Nexø, M. A. (2014) · Cited by 1
Samuels, M. H. (2020) · Clinical Thyroidology · doi:10.1089/ct.2020;32.548-551 · Cited by 1
Boronat, M., González-Lleó, A. M., Rodríguez-Pérez, C., Feldt‐Rasmussen, U., López-Plasencia, Y., Rasmussen, Å. K., Alberiche-Ruano, M. P., Hegedűs, L. D., Alvarado-Martel, D., Bonnema, S. J., et al. (2018) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2018.06.005 · Cited by 1
Objective Markers of Thyroid Hormone Homeostasis in Levothyroxine Versus Liothyronine Monotherapies
McAninch, E. A. (2022) · Clinical Thyroidology · doi:10.1089/ct.2022;34.389-391 · Cited by 1
“However, the ability of levothyroxine to “normalize” all sequelae of hypothyroidism has come into question, as a minority of patients can experience residual symptoms despite its use to normalize serum thyrotropin (TSH) (2,3).”
InfluentialMonitoring Levothyroxine Replacement in Primary Hypothyroidism
Horvath, A. R. (2008) · Wiley eBooks · doi:10.1002/9780470696323.ch19 · Cited by 1
Thyroid hormone, metabolism and the brain
Klieverik, L. P. (2009) · Data Archiving and Networked Services (DANS) · Cited by 1
Hashimoto-Thyreoiditis: Mehr als nur Schilddrüsenhormonmangel?
Führer, D. (2010) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
Hyperthyroidism : Incidence and long term quality-of-life
Abraham‐Nordling, M. (2008) · Figshare · Cited by 1
Returning to a Patient-Centered Approach in the Management of Hypothyroidism
Schneiderhan, J. R., & Zick, S. M. (2020) · The Annals of Family Medicine · doi:10.1370/afm.2602 · Cited by 1
Symptoms in Patients Being Treated for Hypothyroidism: New Data in a Continuing Controversy
Mammen, J. S., & Cooper, D. S. (2023) · Thyroid · doi:10.1089/thy.2023.0307 · Cited by 2
“4 While most patients appear to be doing well with this therapeutic approach, Saravanan et al. 5 found that even among those with normal serum TSH levels, hypothyroid patients responding to a survey were more likely than controls to have a significant symptom burden, based on scores on a validated…”
Relevanz von Schilddrüsenhormonen als Screeninginstrument für postpartale Depression
Große, H. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-10533
Pearce, E. N. (2014) · Clinical Thyroidology · doi:10.1089/ct.2014;26.208-210
Combination therapy in a hypothyroid patient intolerant of elevated thyroxine
Singer, A. J. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80054-7
T4 versus T3 and T4: Is It a Real Controversy?
Weetman, A. P. (2007) · Hormone Research in Paediatrics · doi:10.1159/000097569
Thyroid Hormone Treatment for Differentiated Thyroid Carcinoma: What Drug, How Long, What Dose?
Piantanida, E., Compri, E., Gandolfo, M., Sassi, L., Dionigi, G., Lai, A., Tanda, M. L., & Bartalena, L. (2009) · Current Cancer Therapy Reviews · doi:10.2174/157339409789712717
“Some patients under L-T4 replacement therapy complain of hypothyroid-like symptoms, particularly persisting changes in cognitive functioning and psychological wellbeing, in spite of the normalization of biochemical parameters (free thyroid hormones, TSH) [38-40].”
BackgroundL-T4 and L-T3 combined treatment vs L-T4 alone
Wiersinga, W. M. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.06.008
Fanghänel, G., Sánchez‐Reyes, L., Herrera, A. E., Rodríguez, I. C. R., Torres, P. E. B., Violante, R., & del Castillo, M. M. F. (2012) · Medicina Interna de México
Ward, L. S., & Kloos, R. T. (2013)
Thyroid Disorders and Women's Health
Redmond, G. P. (2004) · Journal watch · doi:10.1056/wh200407080000003
Development and Validation of a Health Status Scale for Korean Hypothyroid Patients
Yeoum, S., & Kim, K. (2016) · Indian Journal of Science and Technology · doi:10.17485/ijst/2016/v9i28/87801
Pearce, E. N. (2016) · Clinical Thyroidology · doi:10.1089/ct.2016;28.200-202
Pearce, E. N. (2016) · Clinical Thyroidology · doi:10.1089/ct.2016;28.376-378
Lee, J., Chung, Y. S., & Lee, Y. D. (2017) · Korean Journal of Clinical Oncology · doi:10.14216/kjco.17005
“Despite apparently adequate thyroid hormone replacement, many patients experience persistent hypothyroid symptoms after receiving total thyroidectomy [1,2].”
BackgroundCole, M., Hynes, A. M., Howel, D., Hall, L., Abinun, M., Allahabadia, A., Barrett, T., Boelaert, K., Drake, A. J., Dimitri, P., et al. (2019) · Yearbook of pediatric endocrinology · doi:10.1530/ey.16.3.13
Hennessey, J. V. (2019) · Springer eBooks · doi:10.1007/978-3-030-22720-3_20
Wémeau, J.-L. (2020) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2020.02.001
Ajwah, I., Ajwah, A. M., Albalawi, H. M., Alsaqqa, E. M., Alshehri, M. A., Alnahyah, O. A., Alatawi, E. S., & Mirghani, H. O. (2020) · Australasian Medical Journal · doi:10.35841/1836-1935.13.3.86-91
Psychiatric Disorders and Thyroid Disease
Hennessey, J. V. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-05885-8.00041-6
Taïeb, D. (2020) · Médecine Nucléaire · doi:10.1016/j.mednuc.2020.06.003
NHG-Standaard Schildklieraandoeningen
Wessels, P., van Rijswijk, E., Boer, A., & van Lieshout, J. (2011) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8279-8_71
Elsherbiny, T. M. (2019) · The Egyptian Journal of Internal Medicine · doi:10.4103/ejim.ejim_79_19
EXTENDED ABSORPTION OF LIOTHYRONINE FROM POLY-ZINC-LIOTHYRONINE (PZL) IN HUMANSPreprint
Dumitrescu, A. M., Hanlon, E. C., Arosemena, M., Duchon, O., Ettleson, M. D., Giurcanu, M. C., & Bianco, A. C. (2021) · medRxiv · doi:10.1101/2021.06.14.21258437
Chavez, C. P., & Ospina, N. S. (2021) · Clinical Thyroidology · doi:10.1089/ct.2021;33.346-349
The pharmacological management of hypothyroidism
Moolman, L. J. (2021) · South African General Practitioner · doi:10.36303/sagp.2021.2.2.0070
Şahiner, S., & Sarı, O. (2021) · Life and Medical Sciences · doi:10.54584/lms.2022.8
Begum, M. N., Sarker, S. K., Bhuyan, G. S., Islam, M. T., Haque, S., Konika, T. K., Qadri, S. K., Ahmed, T., Banu, H., Sultana, N., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3995419
Clearing Up the Fog: Insights Into Brain Fog Experienced by Patients With Hypothyroidism
Chen, D., & Papaleontiou, M. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2021.12.004
Garla, V. V., Cardozo, L. L. Y., & Lien, L. F. (2018) · Springer eBooks · doi:10.1007/978-3-319-99079-8_2
Mitrović, B., Gluvic, Z. M., Obradovic, M. M., Lačković, M., Samardzic, V. S., Ćirić, J., & Isenović, E. R. (2016) · Medicinska istrazivanja · doi:10.5937/medist1602001m
“U modifikovanom skoru odgovori pod d su se vrednovali sa 4 boda (numerički rangovi odgovora su 0, 1, 2 i 4), što povećava maksimalni zbir skorovanja na 48 (13).”
BackgroundInfluential7 Medical Management of Thyroiditis and Hypothyroidism
(2021) · Thieme Medical Publishers eBooks · doi:10.1055/b-0041-182782
Letter to the Editor: Subclinical Hypothyroidism: Possible Fallacies
(2015) · Clinical Thyroidology · doi:10.1089/ct.2015;27.190-194
Need for Thyroid Hormone Replacement Predicts Poorer Quality of Life after Thyroid Surgery
Udyavar, N. R., & Morris, L. F. (2022) · Clinical Thyroidology · doi:10.1089/ct.2022;34.351-354
“In one study, hypothyroid patients rendered euthyroid on thyroid hormone replacement experienced significant impairment in psychological well-being as compared with age-and sex-matched controls (2).”
Hypothyroidism: An Underestimated Issue
McAninch, E. A. (2023) · Clinical Thyroidology · doi:10.1089/ct.2023;35.264-267
“It is increasingly well recognized that about 15% of patients can experience residual symptoms despite LT4 treatment to normalize serum TSH (6,7).”
InfluentialThyroid-Specific Patient-Reported Outcome Measure (ThyPRO)
Watt, T. (2023) · Springer eBooks · doi:10.1007/978-3-031-17299-1_3857
Davis, A., & Idiculla, J. M. (2024) · Thyroid Research and Practice · doi:10.4103/trp.trp_25_23
Maneewan, S., Manosroi, W., Jesadaporn, P., Phimphilai, M., & Tipduangta, P. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae072
“Levothyroxine replacement may improve QOL scores; however, QOL might not always return to normal, even upon normalization of thyrotropin (TSH) levels [8].”
Personality Traits and Patient Satisfaction in Hypothyroidism
McAninch, E. A. (2024) · Clinical Thyroidology · doi:10.1089/ct.2024;36.272-275
Does Thyroidectomy Offer Quality of Life Advantage for Autoimmune Thyroiditis Patients?
Kumarathunga, D., Kanchana, W. G. P., Ratnayake, P., & Antonypillai, C. (2024) · Sri Lanka Journal of Medicine · doi:10.4038/sljm.v33i2.489
Perros, P. (2024) · Copernicus books · doi:10.1007/978-3-031-58287-5_1
Perros, P. (2024) · Copernicus books · doi:10.1007/978-3-031-58287-5_5
Ghaznavi, S. A. (2024) · Clinical Thyroidology · doi:10.1089/ct.2024;36.365-368
Bipolar Disorder and Endocrine Involvement: Hypothyroidism
Biswanath, R., & Hmar, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_93-1
Correlation of Residual Symptoms With Triiodothyronine (T3) in Patients Treated for Hypothyroidism
Naushad, A. A., Chirag, L. U., Nikitha, S., Sourabh, S., Kolla, B., Selvan, C., Kalra, P., Manjunath, P., & Ganavi, Y. P. (2025) · Cureus · doi:10.7759/cureus.78095
“%) and by Saravanan et al. [15] (46.8%).”
InfluentialImpact of Thyroid Cancer on Behavior and Psychology
Vainer, I., & Yaniv, D. (2025) · Springer eBooks · doi:10.1007/978-3-031-32046-0_109-1
Guglielmi, R., Mian, C., Andreoli, C., Bagnasco, M., Boniardi, M., Menis, E. D., Rimini, M. L. D., Tina, D., Fiorentini, G., Locantore, P., et al. (2025) · L Endocrinologo · doi:10.1007/s40619-025-01601-4
“In ogni caso l’impiego della LT3 è controindicato in pazienti fragili o con patologie cardiovascolari [112, 136–138].”
Sotirović, J., Petrovic, M. G., Milojević, M., Baletić, N., Čukić, O., & Zaletel, I. V. (2025) · Vojnosanitetski pregled · doi:10.2298/vsp241029031s
Precision Thyroid Hormone Therapy for Hypothyroidism
Bianco, A. C., & Beltrão, F. E. D. L. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_24
Bipolar Disorder and Endocrine Involvement: Hypothyroidism
Biswanath, R., & Hmar, B. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_93
Begum, M. N., Sarker, S. K., Islam, M. T., Bhuyan, G. S., Mahtarin, R., Patwary, M. H., Konika, T. K., Qadri, S. K., Ahmed, T., Banu, H., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331474
Impact of Thyroid Cancer on Behavior and Psychology
Vainer, I., & Yaniv, D. (2025) · Springer eBooks · doi:10.1007/978-3-031-73363-5_109
Burlacu, M.-C., Attanasio, R., Hegedüs, L., Nagy, E. V., Papini, E., Perros, P., Sawadogo, K. A., Bex, M., Corvilain, B., Daumerie, C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19313714
Mehran, L., Amouzegar, A., Foroutan, S. M., Masoumi, S., Tohidi, M., Abdi, H., Aghaei, A., Saghafinia, A. E., & Azizi, F. (2024) · Figshare · doi:10.6084/m9.figshare.26613242
Metadata
- Authors
- Saravanan, P., Chau, W. ‐., Roberts, N., Vedhara, K., Greenwood, R., & Dayan, C. M.
- Affiliations
- Weston General Hospital (GB)
- Bristol Royal Infirmary (GB)
- University of Bristol (GB)
- Corresponding author
- Dayan, C. M.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2002-10-22
- Volume
- 57
- Issue
- 5
- Pages
- 577-585
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W1888479777
- Cited by
- 514
- References
- 33
- Citations by year
- 2026: 12 · 2025: 27 · 2024: 26 · 2023: 30 · 2022: 45 · 2021: 33 · 2020: 37 · 2019: 33 · 2018: 27 · 2017: 26 · 2016: 31 · 2015: 21 · 2014: 25 · 2013: 15 · 2012: 16
- FWCI
- 7.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- levothyroxine, thyroid hormone replacement, psychological well-being, thyroid symptoms, thyroid-stimulating hormone, psychiatric morbidity, lethargy, General Health Questionnaire, community-based study, adverse drug reactions, quality of life
- MeSH terms
- Adolescent, Adult, Aged, Drug Administration Schedule, Female, Humans, Hypothyroidism, Male, Middle Aged, Psychiatric Status Rating Scales, Surveys and Questionnaires, Regression Analysis, Thyrotropin, Thyroxine, Chi-Square Distribution, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
